1 Dec

PharmaSols - HiRO announcement

Media Release

We are excited to announce that on 30 November 2021 Pharmaceutical Solutions (PharmaSols) was acquired by newly established global CRO, Harvest Integrated Research Organization (HIRO), headquarters based in Shanghai.
 
As part of the HiRO Family, PharmaSols will be unchanged. Same team of regional experts, same leadership, just stronger with a wider service offering, global network and investment in market leading integrated systems and processes.
 
During the past nine months, key personnel within HiRO and PharmaSols have worked together with a shared commitment and vision to form this new global partnership. We are aligned in our commitment to delivering successful clinical trials through a dedicated team of experts, committed to being the global CRO team of choice.
 
PharmaSols is the first addition to HiRO’s global team. Both companies are highly complementary with strong clinical research networks, both globally and throughout Asia and the Pacific. HiRO brings to PharmaSols the ability to operate as a global full service CRO.
 
Our clients will directly benefit from our combined depth and breadth of experience and commitment to deliver quality clinical trials.
 
HiRO is led by CEO Karen Chu, a highly experienced senior executive in the global clinical research industry. Prior to recently establishing HiRO with a team of CRO/Biotech/Pharma veterans, Karen was Parexel’s Head of Global Clinical Operations. The HiRO Team identified that changes in the international clinical trials landscape meant that global sponsors required greater support to navigate complex regulatory and clinical trial requirements. A team of global experts were needed to work more collaboratively with biotechs and pharmaceutical companies to deliver effective cross border solutions in clinical trial design, execution and project management.
 
“We immediately recognised kindred spirits in the team at PharmaSols. Highly talented and dedicated, their combination of professionalism and flexibility is exactly what biotechs need from a CRO partner.” - Karen Chu, CEO
 
We look forward to our future together, working and growing alongside our global business partners and sponsors to deliver effective clinical trials solutions.
 
Better together – “Kia pai te kotahi”

  Karen Chu | Linked In
  HiRO

Jacquie Palmer
PharmaSols

 

Break

About PharmaSols: 


Pharmaceutical Solutions (PharmaSols) is a CRO with over 20 years of experience delivering Phase 1-4 clinical trials across Australia and New Zealand. The AU/NZ region is renowned for its world-class clinicians, exceptional healthcare systems, tax initiatives, and streamlined ethics and regulatory timelines.

With clinical trial data from this region being compliant with the requirements of both the Food & Drug Administration (FDA) and the  European Medicine Agency (EMA), global clinical trial sponsors take advantage of this growing research hub as a cost-effective solution for global clinical trials. The PharmaSols team has extensive international experience with large pharmaceutical, medical device, and biotech organizations, including expertise across a wide variety of therapeutic areas. Supported by a network of trusted hospital and private sites, the PharmaSols team consistently delivers rapid study start-up solutions, delivers participant recruitment and retention targets, and provides quality trial outcomes.
Break

About HiRO: 


Harvest Integrated Research Organization (HiRO) is a globally oriented innovative clinical research organization (CRO) with its headquarters in Shanghai. With global operations and integration capabilities, the company is dedicated to providing its clients with a full range of solutions and services.

HiRO strives to become a market-leading, integrated global clinical research organization that works hand-in-hand with biotech companies and pharmaceutical companies to bring new products from the laboratory to the market, providing more effective solutions for patients worldwide.

Other News

How Biotechs can utilise Australia and New Zealand to extend seasonal clinical trials and rescue studies

Randomised, controlled trials are considered the gold standard in assessing the safety and effectiveness of potential new medicines and therapies.

Read more
The Effect of the Pandemic on locations for conducting clinical trials for Biotechs

Through the spring of 2020, it became evident that the Covid-19 pandemic would have a dual impact on the clinical research sector. While it has provided the opportunity to conduct research for vaccines, treatments, and diagnostic tests for COVID-19; it has also acted as a major disruptive force, halting trials in their tracks, and exacerbating existing fragilities within the sector.

Read more
Global Clinical Trials take advantage of significant Australian R&D tax incentives

Australia and New Zealand are well-established regions for international clinical trials.  Global sponsors understand the region’s ability to deliver quality research outcomes; rapid start-up, recruitment and participant retention, streamlined ethics and regulatory pathways, internationally accepted quality data from world-leading research facilities and Investigators. 

Read more